CEO Bo Rode Hansen interviewed by MedWatch about rights issue

CEO Bo Rode Hansen has been interviewed by MedWach about the announced rights issue (subscription required)

“Nyslået topchef vil rejse 171 mio. kr. til kræftselskab”: BRH MedWatch interview on 17NOV2020